Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment.
Catherine GutierrezAziz M Al'KhafajiEric BrennerKaitlyn E JohnsonSatyen H GohilZiao LinBinyamin Asher KnisbacherRussell E DurrettShuqiang LiSalma ParvinAnat BiranWandi ZhangLaura RassentiThomas J KippsKenneth J LivakDonna S NeubergAnthony G LetaiGad A GetzCatherine J WuAmy BrockPublished in: Nature cancer (2021)
Lineage-tracing methods have enabled characterization of clonal dynamics in complex populations, but generally lack the ability to integrate genomic, epigenomic and transcriptomic measurements with live-cell manipulation of specific clones of interest. We developed a functionalized lineage-tracing system, ClonMapper, which integrates DNA barcoding with single-cell RNA sequencing and clonal isolation to comprehensively characterize thousands of clones within heterogeneous populations. Using ClonMapper, we identified subpopulations of a chronic lymphocytic leukemia cell line with distinct clonal compositions, transcriptional signatures and chemotherapy survivorship trajectories; patterns that were also observed in primary human chronic lymphocytic leukemia. The ability to retrieve specific clones before, during and after treatment enabled direct measurements of clonal diversification and durable subpopulation transcriptional signatures. ClonMapper is a powerful multifunctional approach to dissect the complex clonal dynamics of tumor progression and therapeutic response.
Keyphrases
- single cell
- chronic lymphocytic leukemia
- rna seq
- high resolution
- drug delivery
- gene expression
- high throughput
- endothelial cells
- transcription factor
- cancer therapy
- depressive symptoms
- poor prognosis
- young adults
- radiation therapy
- single molecule
- oxidative stress
- locally advanced
- induced pluripotent stem cells
- combination therapy
- childhood cancer
- high speed